Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Aashish Kabra

Concepts (80)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
3
2018
223
0.700
Why?
Kidney Neoplasms
3
2018
405
0.610
Why?
5-alpha Reductase Inhibitors
1
2018
16
0.590
Why?
Contraceptives, Oral
1
2018
38
0.570
Why?
Prostatic Hyperplasia
1
2018
41
0.560
Why?
Urinary Bladder, Neurogenic
1
2015
39
0.440
Why?
Anxiety
1
2015
1082
0.270
Why?
Caregivers
1
2015
932
0.250
Why?
Depression
1
2015
1483
0.230
Why?
Quality of Life
1
2015
2999
0.190
Why?
Dutasteride
1
2018
5
0.150
Why?
Finasteride
1
2018
36
0.150
Why?
Sirolimus
1
2018
277
0.130
Why?
Contraception
1
2018
166
0.120
Why?
Urinary Bladder Neoplasms
1
2018
256
0.120
Why?
Ovarian Neoplasms
2
2018
580
0.120
Why?
Sickness Impact Profile
1
2015
57
0.110
Why?
Incidence
2
2018
2794
0.110
Why?
Age Distribution
1
2015
395
0.110
Why?
Sex Distribution
1
2015
379
0.110
Why?
Prostatic Neoplasms
2
2018
1048
0.100
Why?
Self Report
1
2018
856
0.100
Why?
Colorectal Neoplasms
2
2018
802
0.100
Why?
Glomerular Filtration Rate
1
2017
750
0.100
Why?
Follow-Up Studies
2
2018
5200
0.090
Why?
Longitudinal Studies
1
2018
2902
0.080
Why?
Smoking
1
2018
1601
0.080
Why?
Prognosis
2
2018
4073
0.080
Why?
Hypertension
1
2018
1252
0.080
Why?
Kidney
1
2017
1482
0.070
Why?
Hemopexin
1
2009
28
0.070
Why?
Matrix Metalloproteinases
1
2009
95
0.070
Why?
Lung Neoplasms
2
2018
2560
0.070
Why?
Prevalence
1
2015
2772
0.070
Why?
Risk Factors
2
2018
10438
0.070
Why?
Mass Screening
1
2015
1310
0.060
Why?
Aged
4
2018
24574
0.060
Why?
Postoperative Complications
1
2018
2797
0.060
Why?
Obesity
1
2018
3004
0.060
Why?
Male
5
2018
69783
0.050
Why?
Female
5
2018
75515
0.050
Why?
Cross-Sectional Studies
1
2015
5636
0.050
Why?
Infant, Newborn
1
2015
6275
0.050
Why?
Middle Aged
3
2018
34434
0.050
Why?
Infant
1
2015
9818
0.040
Why?
Child, Preschool
1
2015
11457
0.040
Why?
Ribosomal Protein S6
1
2018
15
0.040
Why?
Humans
5
2018
141187
0.040
Why?
Cystectomy
1
2018
42
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2018
129
0.030
Why?
Nephrons
1
2017
22
0.030
Why?
Organ Sparing Treatments
1
2017
36
0.030
Why?
Multidetector Computed Tomography
1
2017
40
0.030
Why?
Programmed Cell Death 1 Receptor
1
2018
257
0.030
Why?
B7-H1 Antigen
1
2018
221
0.030
Why?
Preoperative Period
1
2017
142
0.030
Why?
Urinary Bladder
1
2018
194
0.030
Why?
Nephrectomy
1
2017
157
0.030
Why?
Postoperative Period
1
2017
355
0.030
Why?
Tumor Burden
1
2017
312
0.030
Why?
Adolescent
1
2015
22007
0.030
Why?
Child
1
2015
22308
0.030
Why?
Phosphorylation
1
2018
1768
0.030
Why?
Clinical Decision-Making
1
2017
339
0.030
Why?
Imaging, Three-Dimensional
1
2017
567
0.020
Why?
Internet
1
2017
690
0.020
Why?
Adult
1
2015
39177
0.020
Why?
Software
1
2017
676
0.020
Why?
Predictive Value of Tests
1
2017
2070
0.020
Why?
Cell Proliferation
1
2018
2504
0.020
Why?
T-Lymphocytes
1
2018
2002
0.020
Why?
Disease Models, Animal
1
2018
4404
0.020
Why?
Catalytic Domain
1
2009
224
0.020
Why?
Mice, Inbred C57BL
1
2018
5887
0.020
Why?
Drosophila melanogaster
1
2009
237
0.020
Why?
Blotting, Western
1
2009
1234
0.020
Why?
Animals
2
2018
37657
0.010
Why?
Mice
1
2018
18048
0.010
Why?
United States
1
2018
15220
0.010
Why?
Retrospective Studies
1
2017
16273
0.010
Why?
Kabra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)